This Under-The-Radar Biotech’s Unique Approach To Drug Development Could Supercharge Your Portfolio

With potential COVID-19 vaccines and therapeutics garnering most of the attention this year in the biotech space, the biotech stock featured in today’s article, which has “a unique approach to the business of drug development” for genetic diseases, has been flying under the radar. But with a slew of potential blockbuster drugs in late-stage clinical trials, the author sees this as “a growth stock that can supercharge your portfolio.” CLICK HERE.